Abstract
Several varieties of ocular pathology are associated with acquired cutaneous hypomelanosis (leukoderma; vitiligo). Our current study was undertaken to investigate the relationship between ophthalmologic disorders and a specific depigmentary phenomenon, the vitiligolike leukoderma of cutaneous melanoma. Over the past 14 years, eight patients with cutaneous melanoma and widespread areas of hypopigmentation were identified at the Pigmented Lesion Clinic of the Massachusetts General Hospital. The seven patients who underwent ophthalmologic examination had pigment-related ocular abnormalities. Among these were inflammations of the uveal tract in three patients, heterochromia in two, halo nevi of the choroid in one, and hypopigmentation and/or atrophy of the retinal pigment epithelium or choroid in four. Our findings demonstrate that ocular disease may be a component in a syndrome consisting also of cutaneous melanoma and vitiligolike leukoderma and suggest the need for complete ophthalmologic examinations in patients with melanoma and leukoderma.
Similar content being viewed by others
References
Albert DM, Sober AJ, Fitzpatrick TB (1978) Iritis in patients with cutaneous melanoma and vitiligo. Arch Ophthalmol 96: 2081–2084
Albert DM, Nordlund JJ, Lerner AB (1979a) Ocular abnormalities occurring with vitiligo. Ophthalmology 86: 1145–1158
Albert DM, Nordlund JJ, Lerner AB (1979b) Ocular changes in vitiligo. Pigm Cell 5: 62–72
Albert DM, Todes-Taylor N, Wagoner M, Nordlund JJ, Lerner AB (1982) Vitiligo or halo nevi occurring in two patients with choroidal melanoma. Arch Dermatol 118: 3436
Albert DM, Wagoner MD, Pruett RC, Nordlund JJ, Lerner AB (1983) Vitiligo and disorders of the retinal pigment epithelium. Br J Ophthalmol 67: 152–166
Allison JR, Curtis AC (1955) Vitiligo and pernicious anemia. Arch Dermatol 72: 407–408
Bor S, Friel M, Chanarin I (1969) Vitiligo and its aetiological relationship to organ-specific autoimmune disease. Br J Dermatol 81: 83–88
Clark WH, Goldman LI, Mastrangelo MJ (1977) Human malignant melanoma. Grune and Stratton, New York
Copeman PWM, Elliot PG (1976) Melanoma cytoplasmic humoral antibody test. Br J Dermatol 64: 565–568
Corcelle L, Verin P, Cohadon F (1963) Sur un cas de maladie de Harad. Rev Neurol (Paris) 108: 813–814
Cremona AC, Alexandrinia AM (1963) Vitiligo, poliosis y degeneracion macular unilateral. Arch Oftal B Aires 36: 102–106
Cunliffe WJ, Hall R, Newell DJ (1968) Vitiligo, thyroid disease and autoimmunity. Br J Dermatol 80: 136–139
Dawber RPR (1968) Vitiligo in mature onset diabetes. Br J Dermatol 80: 275–278
Duke-Elder S, Perkins E (1966) System of ophthalmology, vol 9. C.V. Mosby, St. Louis
Fields JP, Fragola L, Hadley TP (1971) Hypoparathyroidism, candidiasis, alopecia and vitiligo. Arch Dermatol 103: 687–689
Fisher M, Fitzpatrick TB (1970) Candidiasis, vitiligo, Addison's disease and hypoparathyroidism. Arch Dermatol 102: 110–111
Friel JP (1974) Dorland's Illustrated Medical Dictionary, 25th edn. W.B. Saunders, Philadelphia
Gass JD (1981) Vitiliginous chorioretinitis. Arch Ophthalmol 99: 1778–1787
Grunnet I, Howitz J, Reymann F, Schwartz M (1970) Vitiligo and pernicious anemia. Arch Dermatol 101: 82–85
Harad E (1926) Clinical study of non-suppurative choroiditis — report of acute diffuse choroiditis. Acta Soc Ophthalmol Jpn 30: 356
Hertz KC, Gazze LA, Kirkpatrick CH, Katz SI (1977) Autoimmune vitiligo-detection of antibodies to melanin producing cells. N Engl J Med 297: 633–637
Howitz J, Rehfeld JF (1974) Serum gastrin in vitiligo. Lancet I: 831–834
Howitz J, Schwartz M (1971) Vitiligo; achlorhydria and pernicious anemia. Lancet I: 1331–1335
Howitz J, Brodthagen H, Schwartz M, Thomsen K (1977) Prevalence of vitiligo. Arch Dermatol 113: 47–52
Hutchinson J (1892) A case of blanched eyelashes. Arch Surg 4: 357–358
Koh HK, Sober AJ, Nakagawa H, Albert DM, Mihm MC, Fitzpatrick TB (1983) Malignant melanoma and vitiligo-like leukoderma — an electron microscopic study. J Am Acad Dermatol 9: 696–708
Koyanagi Y (1929) Dsyaskusis, Alopecia und Poliosis bei schwerer Uveitis nicht tratischen Ursprungs. Klin Monatsbl Augenheilkd 81: 210–22
Lerner AB (1959) Vitiligo. J Inv Dermatol 32: 285–310
Lerner AB (1971) On the etiology of vitiligo and gray hair. Am J Med 51: 141–147
Lerner AB, Nordlund JJ (1978) Vitiligo. What is it? Is it important? JAMA 239: 1183–1187
Lerner AB, Nordlund JJ, Albert DM (1977) Pigment cells of the eyes of people with vitiligo. N Engl J Med 296: 232
McGregor BC, Katz HI, Doe RP (1972) Vitiligo and multiple glandular insufficiencies. JAMA 219: 734–735
Milton AU, McCarthy WH, Carlon A (1971) Malignant melanoma and vitiligo. Australas J Dermatol 12(3): 131–142
Mitchell MS, Nordlund JJ, Lerner AB (1980) Comparison of cell-mediated immunity to melanoma cells in patients with vitiligo, halo nevi, or melanoma. J Inv Dermatol 75: 144–147
Moschella SL (1979) Dermatology update. Elsevier North Holland, New York, pp 411–432
Nettleship E (1883/1884) A case of sympathetic ophthalmitis with whitening of the eyelashes. Trans Ophthalmol Soc UK 4: 83
Nirankari MS, Khan KK, Mather RP (1969) Uveal malignant melanoma with leukoderma. J All India Ophthalmol Soc 16: 63
Nordlund JJ, Lerner AB (1982) Vitiligo. It is important. Arch Dermatol 118: 1–7
Nordlund JJ, Raylor NT, Albert DM, Wagoner MD, Lerner AB (1981) The prevalence of vitiligo and poliosis in patients with uveitis. J Am Acad Dermatol 4: 528–536
Nordlund JL, Kirkwood JM, Forget BM, Milton G, Albert DM, Lerner AB (1986) Vitiligo in patients with metastatic melanoma: a good prognostic sign. J Am Acad Dermatol (in press)
Ochi Y, Degront L (1969) Vitiligo in Grave's disease. Ann Intern Med 71: 935, 940
Ortonne JP, Mosher DB, Fitzpatrick TB (1983) Vitiligo and other hypomelanoses of hair and skin. Plenum Press, New York
Perry HD, Font RL (1977) Clinical and histopathologic observations in severe Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 83: 242–254
Shields JA (1983) Diagnosis and management of intraocular tumors. C.V. Mosby, St. Louis
Sober AJ, Haynes HA (1978) Uveitis, poliosis, hypomelanosis and alopecia in a patient with malignant melanoma. Arch Dermatol 114: 4391–441
Takahashi M, Sober AJ, Mosher DB, Fitzpatrick TB, Farinelli WA (1979) Vitiligo-like leukoderma in patients with metastatic malignant melanoma. Pigm Cell 5: 73–87
Tay W (1892) Disease of the eyelids. A case of symmetrical whitening of the eyelashes and eyebrows with sympathetic ophthalmia. Trans Ophthalmol Soc UK 12: 29–30
Vogt A (1906) Frühzeitiges Ergrauen der und Bemerkungen über den sogenannten plötzlichen Eintritt dieser Veränderung. Klin Monatsbl Augenheilkd 44: 228–242
Vladykova J, Singer J (1964) Harada's disease. Cesk Otolaryngol 20: 369–373
Wagoner MD, Albert DM, Lerner AB, Nordlund JJ (1986) Vitiligo and ocular disease — new observations. Am J Ophthalmol 96: 16–26
Author information
Authors and Affiliations
Additional information
Work supported in part by NIH Grant EY01917
Rights and permissions
About this article
Cite this article
Chang, M.A., Fournier, G., Koh, H.K. et al. Ocular abnormalities associated with cutaneous melanoma and vitiligolike leukoderma. Graefe's Arch Clin Exp Ophthalmol 224, 529–535 (1986). https://doi.org/10.1007/BF02154741
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02154741